Long term, prospective, non-interventional, multicenter, double-blinded parallel-cohort study monitoring effectiveness and tolerability of teriflunomide (Aubagio®) in the progress of disability in patients with MS - Κουτουκόγλου, Πρόδρομος. ([χ.ό.], 2016)